Sarcoma News & Features
Mesenchymal chondrosarcoma, which often affects young adults, is among the deadliest cancers.
Adult patients with sarcoma experience significant symptom burden, which has a strong negative impact on health-related quality of life.
Data from a phase 2 trial supports continuation of trabectedin for patients with advanced soft-tissue sarcoma (STS) who have not progressed after six courses of treatment.
Image-guided radiotherapy can effectively treat soft tissue sarcomas in the extremities.
A combination of experimental drugs caused Ewing sarcoma tumors to disappear in mice.
A diagnosis of soft-tissue sarcoma can leave many patients unsure of what to do next. This fact sheet provides more information about this type of cancer and lists sources of support.
- Overweight breast cancer survivors treated with tamoxifen may have higher risk for arm lymphedema
- Poor survival in multiple myeloma patients linked to genetic variation
- Unraveling of molecular changes in acute lymphoblastic leukemia (ALL) opens new treatment options
- Profile of neratinib and its potential in the treatment of breast cancer
- Religiousness and spirituality have a significant impact on cancer patients' overall health and outcomes
- Race and institutional factors play important roles in pharmacogenomics trial participation
- Research group looking to bring Cuba's lung cancer vaccine to the United States
- Patients with advanced cancer prefer open, effective communication
- 26 percent of senior oncology patients use alternative therapies
- Older, younger patients with metastatic pancreatic cancer have similar survival
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|